What the Dubai Longevity Authority Means for the Future of Longevity in Dubai

On 10 June 2026, Dubai issued Law No. 17 of 2026 establishing the Dubai Longevity Authority (DLA), a dedicated regulator tasked with making the emirate the world's leading hub for regulated longevity, wellness and advanced healthcare. Cities everywhere talk about longevity. Dubai has now written it into law.

For the health-conscious residents who treat their biology with the same seriousness as their careers, this is more than a policy headline. It changes the standard longevity providers will be measured against, and gives residents a clearer basis for judging which services and claims are credible. Here is what the announcement means, and what it does not.

What is the Dubai Longevity Authority?

The Dubai Longevity Authority (DLA) is a government regulator established under Law No. 17 of 2026 to develop Dubai as a global hub for regulated longevity, wellness and advanced healthcare. It is mandated to build a science-driven, risk-proportionate framework spanning the entire sector, from research through to patient care.

The remit deliberately covers everything between the laboratory bench and the individual. According to the Dubai Media Office, the authority will license and supervise the full value chain, and will operate in coordination with established bodies including the Dubai Health Authority, Dubai Health, Dubai Municipality and the Dubai Future Foundation. That cross-government structure signals that longevity is being treated as a coordinated economic and public health priority, not a standalone initiative.

When was it established, and who leads it?

Dubai issued Law No. 17 of 2026 on 10 June 2026 to establish the DLA. His Excellency Helal Saeed Almarri, Director General of the Dubai Department of Economy and Tourism, chairs the authority, which works in coordination with the Dubai Health Authority, Dubai Health, Dubai Municipality and the Dubai Future Foundation.

The leadership structure places the authority at the centre of Dubai's economic agenda rather than treating longevity as a niche medical concern. Almarri described the longevity, wellness and advanced health sector as one of the fastest-growing economic frontiers in the world, and framed the authority's purpose, in his words, as building a "sophisticated, sovereign market for advanced therapeutic products and services."

What does "regulated longevity" actually mean?

Regulated longevity means longevity therapies, diagnostics and products are overseen by a defined framework rather than operating in a grey area. The DLA will license and supervise activity across research, clinical trials, manufacturing, delivery and clinics, aligning the sector with international standards for safety, quality and scientific accountability.

The phrase the law uses, a risk-proportionate framework, matters. It implies regulation calibrated to the evidence behind each intervention, rather than a single blanket rule. For credible providers, that is an opportunity: rigour that used to be a differentiator becomes the baseline expectation everyone is measured against.

Why does it matter for Dubai residents?

For residents, the DLA signals that longevity is becoming an accountable, regulated sector rather than an unregulated wellness trend. It raises the standard for how testing, supplementation and longevity services are delivered, giving health-conscious individuals clearer grounds to judge which providers are credible and which claims are scientifically supported.

This matters because longevity has long mixed serious clinical science with marketing. Unproven supplements and inflated promises have sat alongside genuine, evidence-led practice. A dedicated regulator with authority across the value chain is designed to separate the two, which over time should make it easier to tell providers who work from validated data and qualified clinical interpretation from those who do not.

Is Dubai becoming a global longevity hub?

Dubai is positioning itself as one. The UAE wellness economy reached 40.8 billion dollars in 2024 and is the fastest-growing in the Middle East and North Africa, according to the Global Wellness Institute. The DLA formalises that momentum with a dedicated regulator and a clearer framework for investment.

The economic backdrop is significant. The same research records UAE wellness market growth of 14.3 per cent a year between 2019 and 2024, the fastest in the region. Globally, the personalised medicine segment is now worth around 147 billion dollars and is projected to grow 9.3 per cent a year through 2029, as more people move from reactive care towards diagnostic services and personalised health optimisation. The authority is explicitly designed to support Dubai's economic and social agendas, including the goal of leading on healthy life expectancy, so the regulatory move and the market trend point the same way.

How does evidence-led longevity testing work in Dubai?

Evidence-led longevity testing combines several data layers. EVA™ analyses more than 200 million genetic variants through OmicsEdge, tests over 70 blood biomarkers through Unilabs, and translates the results into personalised supplementation. The daily in-app feature, DEVA™, delivers three insights, three actions and three outcomes each day, turning data into routine.

The principle is that intervention should follow diagnosis. Genetics provide a permanent layer of context, blood biomarkers show how the body is functioning now, and supplementation targets what the data actually shows rather than a generic protocol. To see how the layers fit together, read how the EVA™ method works and the clinical science and standards behind it, or start with understanding your blood biomarkers. What differentiates EVA is not the convenience of at-home collection, but the peer-reviewed methodology beneath it and the clinical interpretation provided on the foundation of EliteVita in Dubai Healthcare City.

What should health-conscious residents do now?

Start with data, not guesswork. Before adopting supplements or protocols, establish a baseline from your genetics and blood biomarkers, then personalise from there. As the DLA raises sector standards, choosing a provider with a peer-reviewed methodology and qualified clinical interpretation becomes the most reliable way to act on credible information.

The practical entry points reflect that order. EVA's Blood Intelligence package (AED 1,099) establishes a biomarker baseline, while the Elite package (AED 2,199) adds genomic analysis for a fuller picture, with personalised supplementation available as an ongoing layer. Whichever route a resident takes, the logic mirrors the one the new authority is encouraging across Dubai: measure first, interpret rigorously, then act. You can start your personalised assessment and work from your own data.

How EVA fits into Dubai's regulated longevity era

EVA™ is a consumer platform built on the clinical foundation of EliteVita in Dubai Healthcare City. Its model, validated analysis through OmicsEdge and clinical interpretation by the EVA team, reflects the accountable, science-led direction the DLA is setting for the sector. EVA welcomes regulatory clarity that raises the standard for everyone.

To be precise about what this is and is not: the DLA is newly established and its detailed framework is still to be implemented, so no provider can yet claim to be DLA-regulated, licensed or endorsed. What EVA can say is that its approach was already built around the principles the authority is formalising, validated methodology and qualified clinical oversight, rather than the marketing-led claims the new framework is designed to discipline.

Conclusion

The establishment of the Dubai Longevity Authority is a turning point for how longevity is practised in the emirate. It moves the sector from an unregulated frontier towards a defined, accountable framework, and confirms Dubai's intent to lead a fast-growing global industry.

Three things are worth holding onto. Regulation raises the floor, so rigour becomes the standard rather than the exception. The most credible longevity work still rests on validated data and qualified clinical interpretation. And the strongest position a resident can take is to act from their own biology rather than from generic advice. Dubai has set the direction. The next step is personal.